CTSH

cathepsin H, the group of Cathepsins|Minor histocompatibility antigens

Basic information

Region (hg38): 15:78921058-78949574

Previous symbols: [ "CPSB" ]

Links

ENSG00000103811NCBI:1512OMIM:116820HGNC:2535Uniprot:P09668AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

No genCC data.

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the CTSH gene.

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the CTSH gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
3
clinvar
3
clinvar
6
missense
16
clinvar
1
clinvar
1
clinvar
18
nonsense
0
start loss
0
frameshift
0
inframe indel
0
splice donor/acceptor (+/-2bp)
1
clinvar
1
splice region
0
non coding
1
clinvar
1
Total 0 0 16 6 4

Variants in CTSH

This is a list of pathogenic ClinVar variants found in the CTSH region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
15-78922189-G-A CTSH-related disorder Likely benign (Nov 09, 2022)3041827
15-78922192-C-T not specified Uncertain significance (May 23, 2024)3078781
15-78922996-T-A not specified Uncertain significance (Sep 22, 2023)3078780
15-78923025-T-G not specified Uncertain significance (Dec 07, 2021)2365802
15-78923062-T-C not specified Uncertain significance (Mar 19, 2024)3270223
15-78925349-G-C not specified Likely benign (May 14, 2024)3270226
15-78925355-T-C not specified Uncertain significance (Dec 21, 2021)2268508
15-78925362-T-C not specified Uncertain significance (Feb 28, 2024)3078779
15-78927712-C-T Likely benign (Jul 11, 2018)758792
15-78927771-C-A not specified Uncertain significance (Aug 21, 2023)2601354
15-78929435-C-G not specified Uncertain significance (Apr 15, 2024)3270225
15-78931491-C-T not specified Uncertain significance (Dec 23, 2022)2406934
15-78931509-GGAA-G Likely benign (Jul 31, 2018)761696
15-78932375-GGACA-G Variant of unknown significance Uncertain significance (Aug 08, 2013)65462
15-78932389-C-T not specified Uncertain significance (May 23, 2023)2515040
15-78932401-C-T not specified Uncertain significance (Apr 18, 2023)2514270
15-78935075-G-A not specified Uncertain significance (Jan 07, 2022)2270773
15-78935684-G-A not specified Uncertain significance (Nov 29, 2021)2341870
15-78935730-C-G not specified Uncertain significance (Oct 18, 2021)2410092
15-78937337-A-G Benign (Jun 12, 2018)736888
15-78937338-T-C not specified Uncertain significance (Jul 09, 2021)2378949
15-78937341-T-C not specified Uncertain significance (Jan 08, 2024)3078777
15-78937349-G-A CTSH-related disorder Likely benign (Feb 14, 2023)3051073
15-78937358-C-T Likely benign (Nov 08, 2018)794489
15-78937403-C-T Benign (Dec 31, 2019)785503

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
CTSHprotein_codingprotein_codingENST00000220166 1228517
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
1.25e-80.80412561001381257480.000549
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense0.5351701910.8910.00001042188
Missense in Polyphen6078.5070.76426893
Synonymous-0.8808272.51.130.00000438593
Loss of Function1.521624.00.6660.00000119260

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.001220.00122
Ashkenazi Jewish0.0001980.000198
East Asian0.003150.00316
Finnish0.00009250.0000924
European (Non-Finnish)0.0003090.000308
Middle Eastern0.003150.00316
South Asian0.0004900.000490
Other0.0001630.000163

dbNSFP

Source: dbNSFP

Function
FUNCTION: Important for the overall degradation of proteins in lysosomes.;
Pathway
Lysosome - Homo sapiens (human);Apoptosis - Homo sapiens (human);Neutrophil degranulation;Surfactant metabolism;Metabolism of proteins;MHC class II antigen presentation;Innate Immune System;Immune System;Adaptive Immune System (Consensus)

Recessive Scores

pRec
0.324

Intolerance Scores

loftool
0.448
rvis_EVS
0.15
rvis_percentile_EVS
64.61

Haploinsufficiency Scores

pHI
0.145
hipred
N
hipred_score
0.197
ghis
0.402

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.808

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Ctsh
Phenotype
respiratory system phenotype; normal phenotype; vision/eye phenotype;

Gene ontology

Biological process
metanephros development;T cell mediated cytotoxicity;adaptive immune response;immune response-regulating signaling pathway;proteolysis;apoptotic process;activation of cysteine-type endopeptidase activity involved in apoptotic process;positive regulation of cell population proliferation;positive regulation of gene expression;positive regulation of epithelial cell migration;neuropeptide catabolic process;bradykinin catabolic process;positive regulation of peptidase activity;antigen processing and presentation;positive regulation of cell migration;zymogen activation;protein destabilization;response to retinoic acid;membrane protein proteolysis;negative regulation of apoptotic process;surfactant homeostasis;neutrophil degranulation;cellular protein metabolic process;positive regulation of angiogenesis;proteolysis involved in cellular protein catabolic process;dichotomous subdivision of terminal units involved in lung branching;ERK1 and ERK2 cascade;cellular response to thyroid hormone stimulus;positive regulation of apoptotic signaling pathway
Cellular component
extracellular region;extracellular space;lysosome;cytosol;secretory granule lumen;cytoplasmic ribonucleoprotein granule;intracellular membrane-bounded organelle;extracellular exosome;alveolar lamellar body;multivesicular body lumen;tertiary granule lumen;ficolin-1-rich granule lumen
Molecular function
endopeptidase activity;aminopeptidase activity;cysteine-type endopeptidase activity;serine-type endopeptidase activity;protein binding;peptidase activity;cysteine-type peptidase activity;cysteine-type endopeptidase activator activity involved in apoptotic process;HLA-A specific activating MHC class I receptor activity;thyroid hormone binding